BSF Enterprise Plc (LON:BSFA)
London · Delayed Price · Currency is GBP · Price in GBX 1.505
-0.245 (-14.00%)
May 21, 2026, 4:14 PM GMT
BSF Enterprise Market Cap
BSF Enterprise has a market cap or net worth of 2.92 million as of May 21, 2026. Its market cap has decreased by -17.85% in one year.
Market Cap
2.92M
Enterprise Value
2.77M
Revenue
52.84K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.51
Market Cap Chart
Since July 26, 2019, BSF Enterprise's market cap has increased from 1.02M to 2.92M, an increase of 187.15%. That is a compound annual growth rate of 16.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 2.92M | 19.73% |
| Dec 31, 2025 | 2.44M | -16.73% |
| Dec 31, 2024 | 2.93M | -72.34% |
| Dec 29, 2023 | 10.59M | -26.28% |
| Dec 30, 2022 | 14.37M | 841.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cizzle Biotechnology Holdings | 13.17M |
| Genflow Biosciences | 11.52M |
| Oxford BioDynamics | 8.15M |
| CRISM Therapeutics | 5.95M |
| OptiBiotix Health | 5.94M |
| Thalia Therapeutics | 5.62M |
| Theracryf | 4.94M |
| Nuformix | 4.44M |